Gastrointestinal Tumor Clinical Trial
Official title:
A Clinical Safety and Efficacy Study on TIL for the Treatment of r/r Gastrointestinal Tumors
This study is to investigate the safety and efficacy of tumor infiltrating lymphocyte (TIL) therapy in patients with malignant refractory/relapsed gastrointestinal tumors. Autologous TILs are expanded from tumor resections or biopsies and infused i.v. into the patient after NMA lymphodepletion treatment with hydroxychloroquine(600mg,single-dose) and cyclophosphamide.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01434069 -
Phase I Trial of Combination of FOLFIRI and SOM 230
|
Phase 1 | |
| Recruiting |
NCT06340620 -
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
|
N/A | |
| Completed |
NCT06022692 -
Hyperthermia Combined With Immune Checkpoint Inhibitor Therapy for Advanced Gastrointestinal Tumours
|
Phase 1/Phase 2 | |
| Completed |
NCT02631590 -
Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma
|
Phase 2 | |
| Recruiting |
NCT05262491 -
A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumor and Other Solid Tumor
|
Phase 1 | |
| Recruiting |
NCT04960943 -
Efficacy and Safety of Pyrotinib in HER2 Positive Gastrointestinal Tumors
|
Phase 2 | |
| Completed |
NCT01625351 -
A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas
|
Phase 1 |